Neuropsychiatric Disorders and COVID-19: What We Know So Far

Neuropsychiatric Disorders and COVID-19: What We Know So Far

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) affects the central nervous system (CNS), which is shown in a significant number of patients with neurological events. In this study, an updated literature review was carried out regarding neurological disorders in COVID-19. Neurological s...

Full description

Bibliographic Details
Main Authors: Fernanda Majolo, Guilherme Liberato da Silva, Lucas Vieira, Cetin Anli, Luís Fernando Saraiva Macedo Timmers, Stefan Laufer, Márcia Inês Goettert
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceuticals
Subjects:
angiotensin-converting enzyme 2 (ACE2)
central nervous system
SARS-CoV-2
Online Access:https://www.mdpi.com/1424-8247/14/9/933

Similar Items

Similar Items